- Home
- NYC vs POCI Comparison
NYC vs POCI Comparison
Compare NYC & POCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYC
- POCI
- Stock Information
- Founded
- NYC 2013
- POCI 1982
- Country
- NYC United States
- POCI United States
- Employees
- NYC N/A
- POCI N/A
- Industry
- NYC Real Estate
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NYC Finance
- POCI Health Care
- Exchange
- NYC Nasdaq
- POCI Nasdaq
- Market Cap
- NYC 27.6M
- POCI 32.4M
- IPO Year
- NYC N/A
- POCI N/A
- Fundamental
- Price
- NYC $10.45
- POCI $4.21
- Analyst Decision
- NYC
- POCI
- Analyst Count
- NYC 0
- POCI 0
- Target Price
- NYC N/A
- POCI N/A
- AVG Volume (30 Days)
- NYC 8.2K
- POCI 7.4K
- Earning Date
- NYC 03-31-2025
- POCI 02-13-2025
- Dividend Yield
- NYC N/A
- POCI N/A
- EPS Growth
- NYC N/A
- POCI N/A
- EPS
- NYC N/A
- POCI N/A
- Revenue
- NYC $62,060,000.00
- POCI $18,682,766.00
- Revenue This Year
- NYC N/A
- POCI N/A
- Revenue Next Year
- NYC $3.18
- POCI N/A
- P/E Ratio
- NYC N/A
- POCI N/A
- Revenue Growth
- NYC N/A
- POCI N/A
- 52 Week Low
- NYC $5.46
- POCI $3.47
- 52 Week High
- NYC $12.52
- POCI $6.90
- Technical
- Relative Strength Index (RSI)
- NYC 50.89
- POCI 24.49
- Support Level
- NYC $10.50
- POCI $4.75
- Resistance Level
- NYC $12.52
- POCI $5.04
- Average True Range (ATR)
- NYC 0.68
- POCI 0.25
- MACD
- NYC -0.04
- POCI -0.08
- Stochastic Oscillator
- NYC 22.18
- POCI 0.00
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.